156130-68-6Relevant articles and documents
Asymmetric synthesis of allylic amines: Via hydroamination of allenes with benzophenone imine
Xu, Kun,Wang, Yu-Hsuan,Khakyzadeh, Vahid,Breit, Bernhard
, p. 3313 - 3316 (2016/05/19)
Rhodium-catalyzed highly regio- and enantioselective hydroamination of allenes is reported. Exclusive branched selectivities and excellent enantioselectivities were achieved applying a rhodium(i)/Josiphos catalyst. This method permits the practical synthesis of valuable α-chiral allylic amines using benzophenone imine as ammonia carrier.
Structure activity studies of the serine-AIB dipeptide domain in 2,3-dihydroisothiazole based growth hormone secretagogues
Evers, Britta,Ruehter, Gerd,Berg, Martina,Dodge, Jeffrey A.,Hankotius, Dirk,Hary, Ulrike,Jungheim, Louis N.,Mest, Hans-Juergen,De La Nava, Eva-Maria Martin,Mohr, Michael,Muehl, Brian S.,Petersen, Soenke,Sommer, Birgit,Riedel-Herold, Grit,Tebbe, Mark J.,Thrasher, Kenneth J.,Voelkers, Silke
, p. 6748 - 6762 (2007/10/03)
A series of growth hormone secretagogues (GHSs) based on 2,3-dihydroisothiazole has been synthesized in the search for a potential treatment of growth hormone deficiency or frailty in the elderly. This paper describes the evaluation of the SAR of the benzyl-d-Ser-aminoisobutyric acid dipeptide fragment. Introduction of substituents in the peptide backbone and in the phenyl ring has been investigated, as well as replacements for the benzyl group and for the AIB residue. A number of modifications resulted in enhanced potency over the parent benzyl-d-Ser-AIB derivative.
Spiro piperidines and homologs promote release of growth hormone
-
, (2008/06/13)
There are disclosed certain novel compounds identified as spiro piperidines and homologs which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such spiro compounds as the active ingredient thereof are also disclosed.